Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynectics Regulatory News (SNX)

Share Price Information for Synectics (SNX)

Share Price is delayed by 15 minutes
Get Live Data
200.00    0.00 (0.00%)
Bid:
195.00
Ask:
205.00
Spread: 10.00 (5.128%)
Market Cap: £34.01m
SNX Live PriceLast checked at - London Stock Exchange

Intraday Synectics Share Chart

Director/PDMR Shareholding

3 May 2016 16:33

RNS Number : 1191X
Synectics PLC
03 May 2016
 

 

3 May 2016

 

 

 

Synectics plc

(the "Company")

Director PDMR shareholding

 

The Company has been notified that the Trustee of the Company's HMRC Approved Employee Share Acquisition Plan ("ESAP") has purchased 13,500 ordinary shares of 20 pence each in the Company in accordance with the ESAP's rules and on behalf of all ESAP participants.

The shares were purchased on 29 April 2016 at a price of 162 pence each in respect of the six month accumulation period ended on 31 March 2016.

Under the terms of the ESAP, participating members, including employees and certain Directors of the Company, contribute a fixed amount to the Trustee on a monthly basis. The Trustee acquires a number of shares in the Company at the end of the six month accumulation period (the "Period") based upon the contributions made in the Period and determined by the lowest share price at either the beginning of the Period or on the date of purchase. In this instance the share price used for the allocation of the number of shares for ESAP purposes was the price per share on the date of purchase (162 pence).

As a result of these purchases, the Company has been notified that Paul Webb and Mike Stilwell, Directors of the Company, have acquired an interest in 463 shares and 555 shares respectively.

Following the share purchase in relation to the ESAP, the interests of Paul Webb and Mike Stilwell in Synectics shares are as follows:

 

Name

Position

Beneficial Interest

Interest in Share Schemes

ResultantTotalInterest

% ofIssuedShare Capital

Paul Webb

Chief Executive

10,000

289,346

299,346

1.68%

Mike Stilwell

Finance Director

6,910

49,129

56,039

0.31%

 

 

For further information, please contact:

Synectics plc

Tel: +44 (0) 1527 850080

Richard Brierley, Deputy Company Secretary

legalandsecretarial@synecticsplc.com

www.synecticsplc.com

Stockdale Securities

Tel: +44 (0) 20 7601 6100

Tom Griffiths / Henry Willcocks

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHEASSDEDAKEFF
Date   Source Headline
8th Jun 20267:00 amRNSEBT Share Purchase
1st Jun 20261:48 pmRNSEBT Share Purchase
20th May 20267:00 amRNSFunding of EBT to Acquire Ordinary Shares and RPT
18th May 202612:48 pmRNSResult of AGM
18th May 20267:01 amRNSBoard Change
18th May 20267:00 amRNSAGM Trading Update
23rd Apr 20261:30 pmRNSCorrection to Notice of Annual General Meeting
14th Apr 20267:00 amRNSPosting of Annual Report & Accounts, Notice of AGM
13th Mar 20262:05 pmRNSDirector dealings
12th Mar 20267:00 amRNSDirector Dealings
9th Mar 202610:20 amRNSDirector Dealings
3rd Mar 20263:30 pmRNSDirector / PCA Dealings
3rd Mar 20267:00 amRNSFinal Results and Strategic Update
24th Feb 202612:15 pmRNSNotice of Final Results and Investor Presentation
23rd Feb 20267:00 amRNSOngoing New Business Momentum
19th Feb 20261:41 pmRNSHolding(s) in Company
19th Jan 20269:00 amRNSHoldings in Company
18th Dec 202510:00 amRNSHolding(s) in Company
17th Dec 20257:00 amRNSFull Year Trading Update
24th Nov 20257:00 amRNS-RExtension of Framework Agreement with Stagecoach
3rd Nov 20257:00 amRNS£1.8 million contract with Bus Eireann
16th Oct 20257:01 amRNSNew Contracts - Traction in Broader Energy Sector
16th Oct 20257:01 amRNSTrading Update
16th Oct 20257:00 amRNSAppointment of Nominated Adviser and Sole Broker
9th Oct 202512:16 pmRNSDirector dealings
2nd Oct 20257:00 amRNSPDMR dealings
2nd Sep 20257:00 amRNSDirector/PDMR Shareholding
29th Aug 20257:00 amRNSPDMR dealings
16th Jul 20257:00 amRNSLeisure & Hospitality Contract Wins
8th Jul 20257:00 amRNSHalf-year Report
19th Jun 20257:00 amRNSAppointment of Chief Financial Officer
9th Jun 20257:00 amRNSTrading Update and Notice of Results
4th Jun 20257:00 amRNSUS$4.8m Contract Extension
21st May 20257:00 amRNSPDMR Dealings
12th May 20257:00 amRNS£1.1 million Contract Award
7th May 20251:00 pmRNSResult of Annual General Meeting
7th May 20257:00 amRNSAGM Trading Update
2nd Apr 20257:00 amRNSPDMR dealings
1st Apr 20257:00 amRNSPosting of Annual Report & Accounts, Notice of AGM
31st Mar 20257:00 amRNS£2.0 million Award
4th Mar 20257:00 amRNSFinal Results
14th Feb 20257:00 amRNSNotice of Final Results and Investor Presentation
27th Jan 20257:00 amRNS$2.2 million Contract Award
13th Jan 20255:30 pmRNSHoldings in Company
6th Jan 20258:40 amRNSHoldings in Company
6th Jan 20258:30 amRNSHoldings in Company
9th Dec 20241:30 pmRNSHoldings in Company
9th Dec 20247:00 amRNSTrading Update
5th Dec 20247:00 amRNS$2.7 million Contract Awards
27th Nov 20247:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.